Delivery Order SPE2DB24D2101-SPE2DB25FKLCJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,743.18 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S pharmaceutical products. This non-competitive, firm fixed-price delivery order was awarded on September 8, 2025, with a completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.80 to AmerisourceBergen Drug Corp for WIXELA 500-50 INHUB 60S, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.28 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a child order under AmerisourceBergen's broader contract vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.97 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product used in respiratory treatment. This firm fixed price delivery order, issued on April 29, 2025, with an ultimate completion date of April 30, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,496.16 to AmerisourceBergen Drug Corp on September 3, 2025, for WIXELA 250-50 inhaler units (60-count). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a...
- The Defense Logistics Agency awarded a $1,290.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for WIXELA 250-50 INHUB 60S, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 12, 2025. This is a non-set-aside, competitively awarded contract issued as a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency (DLA) awarded a $2,488.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 18, 2025, and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhaler units (60-count) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was made without a set-aside designation, and performance will take place at the contractor's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for WIXELA 100-50 inhalers in a 60-count configuration. This $1,430.16 firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was made without a set-aside designation, reflecting competitive...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLCJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,080.48 to AmerisourceBergen Drug Corp on June 3, 2025, for WIXELA 500-50 INHUB 60S, a pharmaceutical product for inhalation treatment. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order draws from AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor supplying a broad range of medications, vaccines, and medical supplies to defense and veteran healthcare systems. The company consistently wins competitively awarded contracts with DLA across multiple therapeutic domains, demonstrating its capability to fulfill federal medical supply requirements. This delivery order represents one of numerous transactions the contractor executes under its prime indefinite delivery vehicle, enabling the supply of pharmaceutical products to support military healthcare operations globally, including support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/3/25 |